Identification and Characterization of a Deletion Mutant of DNA Topoisomerase I mRNA in a Camptothecin-resistant Subline of Human Colon Carcinoma-Reference-Cited by-同舟云学术

Identification and Characterization of a Deletion Mutant of DNA Topoisomerase I mRNA in a Camptothecin-resistant Subline of Human Colon Carcinoma

Published:2000-05 Issue:5 Volume:91 Page:551-559
ISSN:0910-5050
Container-title:Japanese Journal of Cancer Research
language:en
Short-container-title:

Author:

Yanase Kae,Sugimoto Yoshikazu,Tsukahara Satomi,Oh-hara Tomoko,Andoh Toshiwo,Tsuruo Takashi

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2000.tb00980.x/fullpdf

Reference47 articles.

1. Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC 100880);Gottlieb;Cancer Chemother. Rep.,1970

2. Treatment of malignant melanoma with camptothecin (NSC-100880);Gottlieb;Cancer Chemother. Rep.,1972

3. Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer;Moertel;Cancer Chemother. Rep.,1972

4. Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880); correlation with preclinical studies;Muggia;Cancer Chemother. Rep.,1972

5. Toxicity of camptothecin (NSC-100880);Schaeppi;Cancer Chemother. Rep. Part 3,1974

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lanthanide–Cyclen–Camptothecin Nanocomposites for Cancer Theranostics Guided by Near-Infrared and Magnetic Resonance Imaging;ACS Applied Nano Materials;2021-01-04

2. Helix Self-Assembly Behavior of Amino Acid-Modified Camptothecin Prodrugs and Its Antitumor Effect;ACS Applied Materials & Interfaces;2020-01-20

3. Reduced Expression of DNA Topoisomerase I in SF295 Human Glioblastoma Cells Selected for Resistance to Homocamptothecin and Diflomotecan;Molecular Pharmacology;2007-11-05

4. Alteration in Copy Numbers of Genes as a Mechanism for Acquired Drug Resistance;Cancer Research;2004-02-15

5. Cellular resistance to DNA Topoisomerase I-targeting drugs;DNA Topoisomerases in Cancer Therapy;2003